Core Scientific, Inc.
CORZ
$14.73
-$0.43-2.84%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 67.24M | 70.79M | 84.95M | 101.93M | 116.67M |
| Total Other Revenue | 266.94M | 277.64M | 325.96M | 408.74M | 441.01M |
| Total Revenue | 334.18M | 348.43M | 410.91M | 510.67M | 557.68M |
| Cost of Revenue | 300.05M | 318.36M | 347.04M | 377.37M | 402.07M |
| Gross Profit | 34.14M | 30.07M | 63.87M | 133.30M | 155.61M |
| SG&A Expenses | 211.71M | 188.21M | 162.65M | 139.46M | 116.78M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -26.50M | -15.34M | 15.04M | 3.81M | 4.17M |
| Total Operating Expenses | 490.27M | 496.24M | 529.75M | 525.66M | 524.90M |
| Operating Income | -156.08M | -147.81M | -118.84M | -14.99M | 32.78M |
| Income Before Tax | -767.44M | -1.08B | -944.15M | -1.31B | -1.24B |
| Income Tax Expenses | 863.00K | 872.00K | 858.00K | 859.00K | 820.00K |
| Earnings from Continuing Operations | -768.31 | -1.08K | -945.00 | -1.32K | -1.25K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -768.31M | -1.08B | -945.00M | -1.32B | -1.25B |
| EBIT | -156.08M | -147.81M | -118.84M | -14.99M | 32.78M |
| EBITDA | -75.23M | -54.59M | -14.90M | 98.22M | 151.15M |
| EPS Basic | -2.08 | -2.79 | -6.46 | -5.37 | -5.28 |
| Normalized Basic EPS | -1.47 | -2.20 | -3.19 | -4.07 | -3.65 |
| EPS Diluted | -2.08 | -2.80 | -6.46 | -5.51 | -5.42 |
| Normalized Diluted EPS | -1.47 | -2.20 | -3.19 | -4.12 | -3.70 |
| Average Basic Shares Outstanding | 1.26B | 1.23B | 1.09B | 1.01B | 1.09B |
| Average Diluted Shares Outstanding | 1.26B | 1.23B | 1.09B | 1.06B | 1.14B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |